Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy

NCT02595372 is registered in ClinicalTrials.gov with Kathy Miller as lead sponsor.

NCT NCT02595372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02595372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy
Lead sponsor
Kathy Miller
Phase
Phase 2
Overall status
Completed
Start date
November 12, 2015
Completion date
March 1, 2021
Enrollment
42 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the breast